{"hq_id":"hq-p-spe-000128","name":"Transdermal Medication Patches (Adhesive Chemicals, Fentanyl Patch Disposal, Child Access Risk)","category":{"primary":"specialized","secondary":"medical_device","tags":["transdermal patch","fentanyl","adhesive","disposal","child access","medication","dermal","opioid"]},"product_tier":"SPE","overall_risk_level":"moderate","description":"Transdermal patches deliver medication through skin over 1-7 days: fentanyl (pain), nicotine (smoking cessation), estradiol (HRT), lidocaine (pain), scopolamine (nausea). Chemical concerns: adhesive (acrylate or silicone-based — contact dermatitis in 10-15% of users), penetration enhancers (oleic acid, propylene glycol, DMSO), and residual drug in used patches. Fentanyl patch disposal: used patches retain 28-84% of original fentanyl dose — lethal to children if accessed. FDA REMS (Risk Evaluation and Mitigation Strategy): fentanyl patches must include disposal instructions (fold adhesive sides together, flush or use drug take-back). Accidental pediatric fentanyl patch exposure: FDA reports 26 deaths (1997-2018).","synthesis":{"derived_risk_level":"severe","synthesis_confidence":0.757,"synthesis_method":"compound_composition","context_used":"human_child","context_source":"product_users","exposure_modifier":1.05,"vulnerability_escalated":false,"escalation_reason":null,"compounds_resolved":1,"compounds_total":1,"synthesis_date":"2026-05-09","synthesis_version":"1.2.0","methodology_note":"exposure_modifier and adjusted_magnitude are computed from ALETHEIA-calibrated heuristics (route × duration × frequency multipliers, clamped to [0.5, 1.4]). Multipliers are directionally informed by EPA Exposure Factors Handbook (2011) and CalEPA OEHHA but are not regulatory consensus. See /api/methodology for full disclosure."},"hazard_summary":{"sensitive_populations":"children in household (fentanyl patch access), patients with adhesive allergy","overall_risk":"moderate","primary_concerns":["Used fentanyl patches retain 28-84% of original drug (lethal to children)","26 pediatric deaths from accidental fentanyl patch exposure (FDA 1997-2018)","Adhesive contact dermatitis in 10-15% of patch users","Heat increases drug absorption: fever, heating pad, hot bath"],"exposure_routes":"Dermal (intended drug delivery + adhesive chemicals); oral (child ingestion of used patch)"},"exposure":{"routes":["dermal","oral"],"contact_types":["skin_prolonged","oral_direct"],"users":["adult","child"],"duration":"days","frequency":"weekly","scenarios":["Adhesive contact dermatitis from patch (10-15% of users)","Used fentanyl patch accessed by child (28-84% residual drug — lethal)","Penetration enhancer systemic absorption (propylene glycol, oleic acid)","Patch adhesive residue on skin after removal"],"notes":"Fentanyl patch residual drug: 25 ug/hr patch contains 2.55 mg fentanyl initially; after 72 hours, 0.7-2.1 mg remains — lethal dose for child is ~0.012 mg/kg (a 10kg toddler: 0.12 mg). FDA fentanyl patch REMS: mandatory patient counseling, disposal instructions (fold sticky sides, flush or drug take-back), medication guide. Adhesive dermatitis management: rotate application sites, use skin barrier (Flonase nasal spray or Cavilon on skin before patch — improves adhesion and reduces irritation), consider different patch brand (different adhesive formulation). Heat (heating pad, hot bath, fever): increases drug absorption from patch — FDA warning for fentanyl patches."},"consumer_guidance":{"usage_warning":"Fentanyl patches: store securely, apply securely (verify adhesion), dispose immediately after removal — fold sticky sides together and flush (FDA-approved disposal method) or use drug take-back. Keep used and unused patches out of reach of children at all times. Do not apply heat to patch area (increases absorption). Adhesive irritation: rotate sites, try different brand, use skin barrier spray before application. Remove adhesive residue with baby oil or medical adhesive remover.","safer_alternatives":["Drug take-back for used fentanyl patches (DEA-authorized)","Fold and flush used fentanyl patches per FDA guidance","Lock box for unused patch storage (child access prevention)","Skin barrier spray before patch application (reduces dermatitis)"]},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA","regulation":"FDA Fentanyl Patch REMS + DEA Disposal Rule","citation":"FDA REMS for Transdermal Fentanyl; 21 CFR 1317","requirements":"REMS: mandatory patient counseling, medication guide, disposal instructions. FDA flush list: fentanyl patches approved for toilet flushing. DEA: drug take-back programs authorized for controlled substance disposal.","compliance_status":null,"effective_date":null,"enforcing_agency":"FDA / DEA","penalties":null,"source_ref":null}],"certifications":[],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":false,"disposal_guidance":"Used fentanyl patches: fold adhesive together and flush (FDA approved) or drug take-back. Other patches: fold and regular waste. Never place in household trash accessible to children or pets.","hazardous_waste":true,"expected_lifespan":"1-7_days"},"formulation":{"form":"varies","key_ingredients":[],"certifications":[]},"materials":{"common":[],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-org-000011","compound_name":null,"role":"adhesive_component","typical_concentration":null}],"identifiers":{"common_names":["transdermal medication patches (adhesive chemicals, fentanyl patch disposal, child access risk)"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[{"brand":"Mylan (Viatris)","manufacturer":"Viatris","market_position":"mass_market","notable":"Generic transdermal patch manufacturer"},{"brand":"Noven","manufacturer":"Noven Pharmaceuticals","market_position":"professional","notable":"Transdermal drug delivery specialist"},{"brand":"LTS Lohmann","manufacturer":"LTS Lohmann","market_position":"professional","notable":"Transdermal patch manufacturer"}],"brand_examples_disclaimer":"Representative branded products of this category. Concerning ingredients listed in materials.concerning[] apply to the category, not necessarily to every named brand. Specific formulations vary by SKU and may have changed since this record was written; consult the brand's current ingredient label before drawing brand-level conclusions.","sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-25"},{"type":"regulation","title":"FDA Fentanyl Patch REMS + DEA Disposal Rule (FDA REMS for Transdermal Fentanyl; 21 CFR 1317)","jurisdiction":"USA","citation":"FDA REMS for Transdermal Fentanyl; 21 CFR 1317","id":"src_2ad9f617"},{"id":"iarc_100f_form","type":"regulatory","title":"IARC Monographs Volume 100F: Formaldehyde","year":2012,"inherited_from_compound":"hq-c-org-000011"},{"id":"epa_form_iris","type":"regulatory","title":"US EPA IRIS Assessment: Formaldehyde (draft)","year":2010,"inherited_from_compound":"hq-c-org-000011"},{"type":"regulatory","title":"US Food and Drug Administration (FDA)","jurisdiction":"USA","id":"src_82d1cfcd","extraction":"description_reference"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-25","timestamp":"2026-05-14T01:22:13.326Z"}}